Ionis Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Ionis Pharmaceuticals patents 237 in total
| Status | Patent |
|---|---|
Application | Utility: COMPOSITIONS FOR MODULATING C9ORF72 EXPRESSION Filling date: 8 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE Filling date: 8 Sep 2025 Issue date: 5 Dec 2019 |
Grant | Utility: Antisense compounds Filling date: 8 Sep 2025 Issue date: 3 Dec 2019 |
Application | Utility: Modulators of APOL1 Expression Filling date: 8 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: OLIGOMERIC COMPOUNDS COMPRISING ALPHA-BETA-CONSTRAINED NUCLEIC ACID Filling date: 8 Sep 2025 Issue date: 28 Nov 2019 |
Grant | Utility: Methods and compositions for modulating apolipoprotein (a) expression Filling date: 8 Sep 2025 Issue date: 19 Nov 2019 |
Grant | Utility: 2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations Filling date: 8 Sep 2025 Issue date: 19 Nov 2019 |
Application | Utility: MODULATION OF LNC05 EXPRESSION Filling date: 8 Sep 2025 Issue date: 14 Nov 2019 |
Grant | Utility: Methods and compositions for modlating apolipoprotein (A) expression Filling date: 8 Sep 2025 Issue date: 12 Nov 2019 |
Grant | Utility: Antisense compounds targeting apolipoprotein E receptor 2 Filling date: 8 Sep 2025 Issue date: 12 Nov 2019 |
Application | Utility: SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: MODULATION OF TMPRSS6 EXPRESSION Filling date: 8 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: COMPOUNDS AND METHODS FOR USE IN DYSTROPHIN TRANSCRIPT Filling date: 8 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: ANTISENSE OLIGONUCLEOTIDES DIRECTED AGAINST CONNECTIVE TISSUE GROWTH FACTOR AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATION OF SMN2 Filling date: 8 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATION OF TRANSCRIPT PROCESSING Filling date: 8 Sep 2025 Issue date: 24 Oct 2019 |
Grant | Utility: Method for solution phase detritylation of oligomeric compounds Filling date: 8 Sep 2025 Issue date: 22 Oct 2019 |
Application | Utility: ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 17 Oct 2019 |
Grant | Utility: Compositions for modulating C9ORF72 expression Filling date: 8 Sep 2025 Issue date: 15 Oct 2019 |
Grant | Utility: Methods and compounds useful in conditions related to repeat expansion Filling date: 8 Sep 2025 Issue date: 8 Oct 2019 |
Grant | Utility: Allele specific modulators of P23H rhodopsin Filling date: 8 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: Compounds and methods for modulating TMPRSS6 expression Filling date: 8 Sep 2025 Issue date: 17 Sep 2019 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATION OF DYSTROPHIA MYOTONICA-PROTEIN KINASE (DMPK) EXPRESSION Filling date: 8 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: GENE THERAPY AND TARGETED DELIVERY OF CONJUGATED COMPOUNDS Filling date: 8 Sep 2025 Issue date: 12 Sep 2019 |
Grant | Utility: Compounds and methods for reducing Tau expression Filling date: 8 Sep 2025 Issue date: 10 Sep 2019 |
Grant | Utility: Compositions for modulating expression of C9ORF72 antisense transcript Filling date: 8 Sep 2025 Issue date: 10 Sep 2019 |
Application | Utility: ANTISENSE COMPOUNDS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 5 Sep 2019 |
Grant | Utility: Modulation of UBE3A-ATS expression Filling date: 8 Sep 2025 Issue date: 3 Sep 2019 |
Application | Utility: COMPOSITIONS FOR MODULATING C9ORF72 EXPRESSION Filling date: 8 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: MODULATION OF HUNTINGTIN EXPRESSION Filling date: 8 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: ANTISENSE COMPOUNDS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: COMPOUNDS AND METHODS FOR REDUCING ATXN3 EXPRESSION Filling date: 8 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: MODULATORS OF DNM2 EXPRESSION Filling date: 8 Sep 2025 Issue date: 8 Aug 2019 |
Grant | Utility: Compounds and methods for increasing antisense activity Filling date: 8 Sep 2025 Issue date: 6 Aug 2019 |
Application | Utility: MODULATION OF PREKALLIKREIN (PKK) EXPRESSION Filling date: 8 Sep 2025 Issue date: 1 Aug 2019 |
Grant | Utility: Modulation of AGPAT5 expression Filling date: 8 Sep 2025 Issue date: 30 Jul 2019 |
Showing 200 to 237 of 237 patents.